Abstract
Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Current Bioinformatics
Title:From Ontology-Based Gene Function to Physiological Model
Volume: 7 Issue: 4
Author(s): Ajay Shiv Sharma, Hari Om Gupta and Petar M. Mitrasinovic
Affiliation:
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Abstract: Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Export Options
About this article
Cite this article as:
Shiv Sharma Ajay, Om Gupta Hari and M. Mitrasinovic Petar, From Ontology-Based Gene Function to Physiological Model, Current Bioinformatics 2012; 7 (4) . https://dx.doi.org/10.2174/157489312803901054
DOI https://dx.doi.org/10.2174/157489312803901054 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
Current Pharmaceutical Design Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
Current Pharmaceutical Design Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal Chemistry Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Recent Patents on Anti-Cancer Drug Discovery Origins and Consequences of AID Expression in Lymphoid Neoplasms
Current Immunology Reviews (Discontinued) Development of New ELISA with High Sensitivity and Selectivity for Bioanalysis of Bevacizumab: A Monoclonal Antibody Used for Cancer Immunotherapy
Current Analytical Chemistry Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update
Reviews on Recent Clinical Trials Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Current Cancer Drug Targets MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics Meet Our Section Editor
CNS & Neurological Disorders - Drug Targets A New Antitumor Agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)-(4-methoxyphenyl) amine, Loaded in Solid Lipid Nanoparticles: Characterization and Pharmacokinetics
Current Nanoscience MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design
Current Medicinal Chemistry Meet Our Regional Editor
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Novel Insights in Molecular Mechanisms of CLL
Current Pharmaceutical Design Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry